Renaissance Capital logo

ZTS News

Eli Lilly's Elanco may be 2018's biggest IPO

Eli Lilly's animal health division Elanco recently filed for a US offering that should come in the fall, raising as much as $3 billion in what may be the year's biggest IPO. Elanco mainly competes with three other giant global animal health companies. ...read more

Renaissance Capital's 2Q 2015 Global IPO Quarterly Review

Following a seasonally calm start to the year, global IPO issuance improved in the second quarter of 2015. Quarterly proceeds increased 29% from the first quarter to $46.6 billion, but still remained down 24% from last year’s levels. IPO proceeds in the...read more

Renaissance IPO Index - Notice of March 2015 Quarterly Changes

The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2015: Additions: Juno Therapeutics Shell...read more

Paining cats and dogs: Nexvet sets terms for $58 million IPO

Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $58 million by offering 4.0 million shares at a price range of $13 to $16. ...read more